Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pirfenidone Oral Tablet
DRUG
2 trials
Sponsors
Instituto de investigación e innovación biomédica de Cádiz
, University of Alabama at Birmingham
Conditions
Complicated Silicosis
Pancreatitis, Acute
Progressive Massive Fibrosis
Silicosis
Phase 1
Safety and Tolerability of Pirfenidone in Acute Pancreatitis
Recruiting
NCT05350371
University of Alabama at Birmingham
Pancreatitis, Acute
Start: 2023-08-01
End: 2027-02-28
Target: 60
Updated: 2025-08-01
Phase 2
Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis
NCT05118256
Instituto de investigación e innovación biomédica de Cádiz
Complicated Silicosis, Progressive Massive Fibrosis, Silicosis
Start: 2021-11-15
End: 2023-11-15
Target: 18
Updated: 2022-01-13
Related Papers
Safety, tolerability and therapeutic efficacy of anti-inflammatory drug pirfenidone in acute pancreatitis patients: Protocol for a randomized pilot clinical trial.
2025-01-13
1 citations